Oscar Health (OSCR)

Healthcare · Healthcare Plans
$32.34 -0.25% on the day Market cap $10.1B 52-week range $10.69 to $34.48 Prices as of Oct 7, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
-5% a year for 10 years

At a market value of $10.1B, Oscar Health's free cash flow of $1.1B (fiscal 2025) would need to grow about -5% a year for the stock to be worth today's price. That is slower than the company has grown its free cash flow over the last 5 years.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Oscar Health's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price-4.8% a year
Free cash flow, last 5 years38.4% a year
Revenue, same period-37.7% a year
Price to free cash flow9.6x

Fundamental grade

C

Five factors scored 1 to 9 from OSCR's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation5
Profitability8
Growth0
Financial health2
Cash efficiency9

Key numbers

P/E (trailing)—
P/E (forward)805.4x
Price / free cash flow9.56x
EV / EBITDA9.07x
Price / sales342.2x
Price / book6.08x
Revenue growth-6.2%
Operating margin2128.9%
Net margin1861.9%
Return on equity26.8%
Dividend yield—
Debt / equity4.47x

Results from SEC filings

Fiscal years, from Oscar Health's 10-K filings. The deep dive has 15+ years, quarters and every line.

Fiscal year20212022202320242025
Revenue$5M$65M$21M$21M$29M
Net income-$573M-$606M-$271M$25M-$443M
Free cash flow-$208M$351M-$298M$950M$1.1B
EPS (diluted)-$3.20-$2.85-$1.22$0.10-$1.69
Operating margin-10094.2%-908.5%-1103.4%278.3%-1386.2%

Superinvestors who own OSCR

From each investor's latest 13F filing (what a 13F shows). 2 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Cliff Asness
AQR Capital Management
Added $16M0.01%Q2 2026
Joel Greenblatt
Gotham Asset Management
Added $708,6360.00%Q2 2026

Insider buying

Open-market purchases by Oscar Health's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

DateInsiderSharesPriceValue
Apr 6, 2026 Mark T Bertolini
CEO
1,000,000$11.92$12M

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when OSCR trades at or below it.

$

Free accounts get 3 price alerts. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does Oscar Health's stock price imply?

At a market value of $10.1B, Oscar Health would need its free cash flow to grow about -5% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 5 years its free cash flow grew 38% a year.

Are Oscar Health insiders buying the stock?

1 open-market insider purchase of OSCR in the last 12 months, from SEC Form 4 filings.

Which superinvestors own Oscar Health?

2 of the superinvestors Investingly tracks hold OSCR in their latest 13F, including Cliff Asness, Joel Greenblatt.

Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.